Oxford Vacmedix UK Ltd.
1 clinical trials · Sponsor
◉ Watch Oxford Vacmedix UK Ltd.
| Record | Firm | Date |
|---|---|---|
| First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine (NCT05104515) | Oxford Vacmedix UK Ltd. | 2021-11-01 |
Track Oxford Vacmedix UK Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.